Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. (ticker: RMTG) is an OTC-listed retail-retail stores, nec company. DredgeCap's structured extraction of RMTG's SEC filings surfaces 20 active risk signals, including 19 late-filing signals, and 1 auditor-change signal. RMTG reported $5.10M in revenue and -$7.81M for the period ending 2025-12-31, with operating cash flow of -$707K. Cash and equivalents stood at $957K (down 17.9% year-over-year). Total assets of $4.49M are exceeded by total liabilities of $39.23M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

RMTG Cash Runway

Months-of-runway analysis for RMTG, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on RMTG

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.